Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study

Simple item page
dc.contributor.authorBhatt, Deepak L
dc.contributor.authorChew, Derek Peng
dc.contributor.authorMukherjee, Debabrata
dc.contributor.authorGilchrist, Ian C
dc.contributor.authorEres, Avichai
dc.contributor.authorSteinhubl, Steven R
dc.contributor.authorResar, Jon R
dc.contributor.authorAlMahameed, Amjad
dc.contributor.authorTang, H Wilson
dc.contributor.authorMcErlean, Ellen
dc.contributor.authorHazen, Stanley L
dc.contributor.authorTan, Walter A
dc.contributor.authorTopol, Eric J
dc.contributor.authorCorbelli, John C
dc.contributor.authorBlankenship, James C
dc.contributor.authorAbdel-Latif, Ahmed
dc.contributor.authorBrennan, Danielle
dc.contributor.authorGrines, Cindy
dc.contributor.authorLeesar, Massoud
dc.date.accessioned2010-07-27T06:03:09Z
dc.date.available2010-07-27T06:03:09Z
dc.date.issued2007en_US
dc.identifier.citationBhatt, D.L., Chew, D.P., Grines, C., Mukherjee, D., Leesar, M., Gilchrist, I.C., Corbelli, J.C., Blankenship, J.C., Eres, A., Steinhubl, S.R., et al., 2007. Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study. American Heart Journal, 154(1), 137-143.en
dc.identifier.doihttps://doi.org/10.1016/j.ahj.2007.03.029en
dc.identifier.issn0002-8703en_US
dc.identifier.rmid2006007069en_US
dc.identifier.urihttp://hdl.handle.net/2328/9980
dc.subject.forgroup1102 Cardiovascular Medicine and Haematologyen_US
dc.titlePeroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR studyen_US
dc.typeArticleen_US
Files
Collections
1102 - Cardiovascular Medicine and Haematology
1102 - Cardiovascular Medicine and Haematology